FDA Opts To Fast Track Constipation Drug
The FDA announced the move on Monday, revealing that it has awarded fast-track status to the intravenous form of methylnaltrexone, which would be used to minister to the postoperative ileus (POI) condition.
POI is an impairment of bowel motility that usually occurs after abdominal surgery.
The average duration of ileus after major abdominal surgery...
To view the full article, register now.